BioPharmSignal logoBioPharmSignal

Biotech News

Avalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform Development

Avalon GloboCare (AVCO)Avalon GloboCareCompany update

AVCO (AVCO) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is avco.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

AVCOAvalon GloboCare2026-06-04 12:00 EST

Avalon GloboCare Appoints Seasoned AI and Finance Executive as Chief Financial Officer

RNACCartesian Therapeutics2026-06-09 11:00 EST

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

IMNNImunon2026-07-23 13:25 EST

IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development

CUECue Biopharma Inc2026-07-13 12:30 EST

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development

INTSIntensity Therapeutics2026-07-01 12:00 EST

Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6

ELTXElicio Therapeutics, Inc.2026-06-15 11:00 EST

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

APVOAptevo Therapeutics2026-05-27 12:05 EST

Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing

View all latest news

Avalon GloboCare

Avalon GloboCare is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

AVCOAvalon GloboCare2026-06-04 12:00 EST

Avalon GloboCare Appoints Seasoned AI and Finance Executive as Chief Financial Officer

AVCOAvalon GloboCare2026-04-21 12:30 EST

Avalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform Development

AVCOAvalon GloboCare2026-03-31 13:00 EST

Avalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video Platform

AVCOAvalon GloboCare2026-02-27 22:30 EST

Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

AVCOAvalon GloboCare2026-02-27 02:20 EST

Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States